Case report: Posterior reversible encephalopathy syndrome, an adverse effect of lenvatinib and pembrolizumab combination therapy, in a patient with advanced endometrial cancer.

Matsuura, Yuki; Nishida, Haruka; Kosaka, Takashi; Shigekawa, Kazuyuki; Takasaki, Kazuki; Ichinose, Takayuki; Hirano, Mana; Hiraike, Haruko; Nagasaka, Kazunori

Matsuura, Yuki; Nishida, Haruka; Kosaka, Takashi; Shigekawa, Kazuyuki; Takasaki, Kazuki; Ichinose, Takayuki; Hirano, Mana; Hiraike, Haruko; Nagasaka, Kazunori.

Afiliação

Matsuura Y; Department of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Nishida H; Department of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Kosaka T; Department of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Shigekawa K; Department of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Takasaki K; Department of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Ichinose T; Department of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Hirano M; Department of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Hiraike H; Department of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Nagasaka K; Department of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.